Sinusoidal obstruction syndrome risk factors: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Sinusoidal obstruction syndrome}} | {{Sinusoidal obstruction syndrome}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of sinusoidal obstruction syndrome are stem cell transplantation, preexisting liver dysfunction and high-dose conditioning regimens. | Common risk factors in the development of sinusoidal obstruction syndrome are stem cell transplantation, preexisting liver dysfunction and high-dose conditioning regimens. | ||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors for sinusoidal obstruction syndrome are:<ref name="pmid12744547">{{cite journal| author=Kumar S, DeLeve LD, Kamath PS, Tefferi A| title=Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. | journal=Mayo Clin Proc | year= 2003 | volume= 78 | issue= 5 | pages= 589-98 | pmid=12744547 | doi=10.4065/78.5.589 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12744547 }} </ref> | Common risk factors for sinusoidal obstruction syndrome are:<ref name="pmid12744547">{{cite journal| author=Kumar S, DeLeve LD, Kamath PS, Tefferi A| title=Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. | journal=Mayo Clin Proc | year= 2003 | volume= 78 | issue= 5 | pages= 589-98 | pmid=12744547 | doi=10.4065/78.5.589 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12744547 }} </ref> | ||
| Line 17: | Line 13: | ||
*High-dose conditioning regimens | *High-dose conditioning regimens | ||
*Allogeneic transplantation (compared with autologous transplantation) | *Allogeneic transplantation (compared with autologous transplantation) | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 02:40, 1 February 2018
|
Sinusoidal obstruction syndrome Microchapters |
|
Differentiating Sinusoidal obstruction syndrome from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sinusoidal obstruction syndrome risk factors On the Web |
|
American Roentgen Ray Society Images of Sinusoidal obstruction syndrome risk factors |
|
Directions to Hospitals Treating Sinusoidal obstruction syndrome |
|
Risk calculators and risk factors for Sinusoidal obstruction syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Common risk factors in the development of sinusoidal obstruction syndrome are stem cell transplantation, preexisting liver dysfunction and high-dose conditioning regimens.
Risk Factors
Common risk factors for sinusoidal obstruction syndrome are:[1]
- Stem cell transplantation
- Preexisting liver dysfunction (elevated transaminases, fibrosis or cirrhosis, low pseudocholinesterase level or low albumin level pretransplantation)
- Presence of hepatic metastases
- Advanced age
- Prior radiation treatment of the liver
- High-dose conditioning regimens
- Allogeneic transplantation (compared with autologous transplantation)
References
- ↑ Kumar S, DeLeve LD, Kamath PS, Tefferi A (2003). "Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation". Mayo Clin Proc. 78 (5): 589–98. doi:10.4065/78.5.589. PMID 12744547.